We have provided the first evidence for specific heteromerization between the α1A-adrenoceptor (α1AAR) and CXC chemokine receptor 2 (CXCR2) in live cells. SB265610. Furthermore Labetalol which is marketed for hypertension as a nonselective β-adrenoceptor antagonist with α1AR antagonist properties was identified as a heteromer-specific-biased agonist exhibiting partial agonism for inositol phosphate production but essentially full… Continue reading We have provided the first evidence for specific heteromerization between the